Focus: Concentric Analgesics is a San Francisco–based biotech focused on drug discovery and development in pain management across neurology, gastroenterology, and ophthalmology. The company is in early-stage clinical development with a lean, focused pipeline.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Stable — net +4 jobs in 30d
21 added, 17 removed. Backfill posture.
Concentric is a high-risk, early-stage play suitable only for career-builders seeking hands-on discovery/development experience and willing to accept significant funding and execution risk.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Concentric Analgesics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Concentric Analgesics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles